Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera
Sonia Jangra, Chengjin Ye, Raveen Rathnasinghe, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 143

Showing 1-25 of 143 citing articles:

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
Wilfredo F. García-Beltrán, Evan C. Lam, Kerri St. Denis, et al.
Cell (2021) Vol. 184, Iss. 9, pp. 2372-2383.e9
Open Access | Times Cited: 1429
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
Rita E. Chen, Xianwen Zhang, James Brett Case, et al.
Nature Medicine (2021) Vol. 27, Iss. 4, pp. 717-726
Open Access | Times Cited: 970
SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients
Daryl Geers, Marc C. Shamier, Susanne Bogers, et al.
Science Immunology (2021) Vol. 6, Iss. 59
Open Access | Times Cited: 520
Age-dependent Immune Response to the Biontech/Pfizer BNT162b2 Coronavirus Disease 2019 Vaccination
Lisa Müller, Marcel Andrée, Wiebke Moskorz, et al.
Clinical Infectious Diseases (2021) Vol. 73, Iss. 11, pp. 2065-2072
Open Access | Times Cited: 474
Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic
Kelvin Kai‐Wang To, Siddharth Sridhar, Kelvin Hei‐Yeung Chiu, et al.
Emerging Microbes & Infections (2021) Vol. 10, Iss. 1, pp. 507-535
Open Access | Times Cited: 297
Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19
Carmen Gómez, Beatriz Perdiguero, Mariano Estéban
Vaccines (2021) Vol. 9, Iss. 3, pp. 243-243
Open Access | Times Cited: 267
The germinal centre B cell response to SARS-CoV-2
Brian J. Laidlaw, Ali H. Ellebedy
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 7-18
Open Access | Times Cited: 213
SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
Daniel Martínez-Flores, Jesús Zepeda–Cervantes, Adolfo Cruz-Reséndiz, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 211
Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?
Ivana Lazarević, Vera Pravica, Danijela Miljanovic, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1192-1192
Open Access | Times Cited: 183
Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies
Lianlian Bian, Fan Gao, Jialu Zhang, et al.
Expert Review of Vaccines (2021) Vol. 20, Iss. 4, pp. 365-373
Open Access | Times Cited: 168
Neutralising antibody escape of SARS‐CoV‐2 spike protein: Risk assessment for antibody‐based Covid‐19 therapeutics and vaccines
Daniele Focosi, Fabrizio Maggi
Reviews in Medical Virology (2021) Vol. 31, Iss. 6
Open Access | Times Cited: 161
Age-dependent immune response to the Biontech/Pfizer BNT162b2 COVID-19 vaccination
Lisa Müller, Marcel Andrée, Wiebke Moskorz, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 157
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
Wilfredo F. García-Beltrán, Evan C. Lam, Kerri St. Denis, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 147
Fast-spreading SARS-CoV-2 variants: challenges to and new design strategies of COVID-19 vaccines
Weilin Zhou, Wei Wang
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 132
Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy
Sindhu Ramesh, Manoj Govindarajulu, Rachel S. Parise, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1195-1195
Open Access | Times Cited: 131
Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity
Hylemariam Mihiretie Mengist, Arnaud John Kombe Kombe, Daniel Mekonnen, et al.
Seminars in Immunology (2021) Vol. 55, pp. 101533-101533
Open Access | Times Cited: 105
Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies
Marta Alenquer, Filipe Ferreira, Diana Lousa, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 8, pp. e1009772-e1009772
Open Access | Times Cited: 93
Declining Levels of Neutralizing Antibodies Against SARS-CoV-2 in Convalescent COVID-19 Patients One Year Post Symptom Onset
Tiandan Xiang, Boyun Liang, Yaohui Fang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 85
CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma
Jiejie Geng, Liang Chen, Yufeng Yuan, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 84
In vitro data suggest that Indian delta variant B.1.617 of SARS‐CoV‐2 escapes neutralization by both receptor affinity and immune evasion
Gilles Augusto, Mona O. Mohsen, Simon Zinkhan, et al.
Allergy (2021) Vol. 77, Iss. 1, pp. 111-117
Open Access | Times Cited: 82
Potency of BNT162b2 and mRNA‐1273 vaccine‐induced neutralizing antibodies against severe acute respiratory syndrome‐CoV‐2 variants of concern: A systematic review of in vitro studies
Maryam Noori, Seyed Aria Nejadghaderi, Shahnam Arshi, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 2
Open Access | Times Cited: 73
Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 Gamma variant transmission in Manaus, Brazil: A test-negative case-control study
Matt D. T. Hitchings, Otávio T. Ranzani, Mario Torres, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 60
The role of B cells in COVID-19 infection and vaccination
Shiru Chen, Fei Guan, Fabio Candotti, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 58
Prevention of host-to-host transmission by SARS-CoV-2 vaccines
Darius Mostaghimi, Caroline N Valdez, Haleigh Tianna Larson, et al.
The Lancet Infectious Diseases (2021) Vol. 22, Iss. 2, pp. e52-e58
Open Access | Times Cited: 57
The ins and outs of SARS-CoV-2 variants of concern (VOCs)
Mostafa Salehi‐Vaziri, Mehdi Fazlalipour, Seyed Mahmood Seyed Khorrami, et al.
Archives of Virology (2022) Vol. 167, Iss. 2, pp. 327-344
Open Access | Times Cited: 49
Page 1 - Next Page

Scroll to top